Action profiles of statins and calcineurin inhibitors during human mixed lymphocyte reaction

Clinical Immunology

Volumn 123, Issue 3, 2007, Pages 324-332

  Takahashi, Hideo Kohka ^a   Iwagaki, Hiromi ^a   Yagi, Takahito ^a   Kanke, Toru ^a   Liu, Keyue ^a   Yoshino, Tadashi ^a   Tanaka, Noriaki ^a   Nishibori, Masahiro ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

Calcineurin inhibitors; IL 18; Mixed lymphocyte reaction; Statins

Indexed keywords

CALCINEURIN INHIBITOR; CD40 ANTIGEN; CYCLOSPORIN A; FLUINDOSTATIN; GAMMA INTERFERON; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 12; INTERLEUKIN 18; LFA 703; LFA 878; PRAVASTATIN; TACROLIMUS; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DRUG EFFECT; DRUG MECHANISM; HUMAN; HUMAN CELL; INTERFERON PRODUCTION; LYMPHOCYTE PROLIFERATION; MIXED LYMPHOCYTE REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTIGENS, CD40; CALCINEURIN; CELL PROLIFERATION; CYCLOSPORINE; FATTY ACIDS, MONOUNSATURATED; HUMANS; HYDROXYMETHYLGLUTARYL COA REDUCTASES; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; IMMUNOSUPPRESSIVE AGENTS; INDOLES; INTERCELLULAR ADHESION MOLECULE-1; INTERFERON TYPE II; INTERLEUKIN-12; INTERLEUKIN-18; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; LYMPHOCYTE CULTURE TEST, MIXED; MEVALONIC ACID; MONOCYTES; NAPHTHALENES; OXAZINES; PRAVASTATIN; T-LYMPHOCYTES; TACROLIMUS;

EID: 34249310984     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2007.02.003     Document Type: Article

References (29)

1. Yagi T., Iwagaki H., Urushihara N., Kobashi K., Nakao A., Matsukawa H., Sadamori H., Inagaki M., and Tanaka N. Participation of IL-18 in human cholestatic cirrhosis and acute rejection in living donor liver transplantation. Transplant. Proc. 33 (2001) 421-425
2. Fujimori Y., Takatsuka H., Takemoto Y., Har H., Okamura H., Nakanishi K., and Kakishita E. Elevated interleukin (IL)-18 levels during acute graft-versus-host disease after allogeneic bone marrow. Br. J. Haematol. 109 (2000) 652-657
3. Ohshima Y., and Delespesse G. T cell derived IL-4 and dendritic cell-derived IL-12 regulate the lymphokine-producing phenotype of alloantigen-primed naive human CD4 T cells. J. Immunol. 158 (1997) 629-636
4. Greenfield E.A., Nguyen K.A., and Kuchroo V.K. CD28/B7 costimulation: a review. Crit. Rev. Immunol. 18 (1998) 389-418
5. Dustin M.L., and Springer T.A. T-cell receptor cross-linking transiently stimulates adhesiveness through LFA-1. Nature 341 (1989) 619-624
6. Zhu S.N., Yamada J., Streilein J.W., and Dana M.R. ICAM-1 deficiency suppresses host allosensitization and rejection of MHC-disparate corneal transplants. Transplantation 69 (2000) 1008-1013
7. Shimizu K., Schonbeck U., Mach F., Libby P., and MitchellHost R.N. CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis. J. Immunol. 165 (2000) 3506-3518
8. Takahashi H.K., Iwagaki H., Tamura R., Yagi T., Yoshino T., Mori S., Tanaka N., and Nishibori M. Effect of antibodies against intercellular adhesion molecule-1, B7, and CD40 on interleukin-18-treated human mixed lymphocyte reaction. J. Pharmacol. Sci. 97 (2005) 447-450
9. Tamura R., Takahashi H.K., Iwagaki H., Yagi T., Mori S., Yoshino T., Nishibori M., and Tanaka N. Effect of beta2-adrenergic receptor agonists on intercellular adhesion molecule (ICAM)-1, B7, and CD40 expression in mixed lymphocyte reaction. Transplantation 77 (2004) 293-301
10. Rizzo M., SivaSai K.S., Smith M.A., Trulock E.P., Lynch J.P., Patterson G.A., and Mohanakumar T. Increased expression of inflammatory cytokines and adhesion molecules by alveolar macrophages of human lung allograft recipients with acute rejection: decline with resolution of rejection. J. Heart Lung Transplant. 19 (2000) 858-865
11. Vathsala A., Goto S., Yoshimura N., Stepkowski S., Chou T.C., and Kahan B.D. The immunosuppressive antagonism of low doses of tacrolimus and cyclosporine. Transplantation 52 (1991) 121-128
12. Jardine A.G. Assessing the relative risk of cardiovascular disease among renal transplant patients receiving tacrolimus or cyclosporine. Transpl. Int. 18 (2005) 379-384
13. Wissing K.M., Unger P., Ghisdal L., Broeders N., Berkenboom G., Carpentier Y., and Abramowicz D. Effect of atorvastatin therapy and conversion to tacrolimus on hypercholesterolemia and endothelial dysfunction after renal transplantation. Transplantation 82 (2006) 771-778
14. Kwak B., Mulhaupt F., Myit S., and Mach F. Statins as a newly recognized type of immunomodulator. Nat. Med. 6 (2000) 1399-1402
15. Weitz-Schmidt G., Welzenbach K., Brinkmann V., Kamata T., Kallen J., Bruns C., Cottens S., Takada Y., and Hommel U. Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site. Nat. Med. 7 (2001) 687-692
16. Weitz-Schmidt G., Welzenbach K., Dawson J., and Kallen J. Improved lymphocyte function-associated antigen-1 (LFA-1) inhibition by statin derivatives: molecular basis determined by X-ray analysis and monitoring of LFA-1 conformational changes in vitro and ex vivo. J. Biol. Chem. 279 (2004) 46764-49771
17. Takahashi H.K., Mori S., Iwagaki H., Yoshino T., Tanaka N., Weitz-Schmidt G., and Nishibori M. Differential effect of LFA703, pravastatin, and fluvastatin on production of IL-18 and expression of ICAM-1 and CD40 in human monocytes. J. Leukoc. Biol. 77 (2005) 400-407
18. Garthwaite E.A., Will E.J., Bartlett C., Richardson D., and Newstead C.G. Patient-specific prompts in the cholesterol management of renal transplant outpatients: results and analysis of underperformance. Transplantation 78 (2004) 1042-1047
19. Wu A.H., Ballentyne C.M., Short B.C., Torre-Amione G., Young J.B., Ventura H.O., Eisen H.J., Radovancevic B., Rayburn B.K., Lake K.D., Yancy Jr. C.W., Taylor D.O., Mehra M.R., Kubo S.H., Fishbein D.P., Zhao X.Q., and O'Brien K.D. Statin use and risks of death or fatal rejection in the Heart Transplant Lipid Registry. Am. J. Cardiol. 95 (2005) 367-372
20. Maggard M.A., Ke B., Wang T., Kaldas F., Seu P., Busuttil R.W., and Imagawa D.K. Effects of pravastatin on chronic rejection of rat cardiac allografts. Transplantation 65 (1998) 149-155
21. Kwak B., Mulhaupt F., Myit S., and Mach F. Statins as a newly recognized type of immunomodulator. Nat. Med. 6 (2000) 1399-1402
22. Barlage S., Hauser I.A., Elbracht R., Abletshauser C., Schmieder R.E., Weidinger G., Lackner K.J., Rothe G., and Schmitz G. Monitoring of peripheral blood cytotoxic T-cells under fluvastatin treatment in renal transplant recipients. J. Biol. Regul. Homeost. Agents 19 (2005) 159-168
23. Katznelson S., and Kobashigawa J.A. Dual roles of HMG-CoA reductase inhibitors in solid organ transplantation: lipid lowering and immunosuppression. Kidney Int., Suppl. 52 (1995) S112-S115
24. Namazi M.R. Statins: novel additions to the dermatologic arsenal?. Exp. Dermatol. 13 (2004) 337-339
25. Prickett T.C., Prickett J.L., McKenzie T.C., and Hart J.L. Characterization of interstitial dendritic cells in human liver. Transplantation 46 (1988) 754-761
26. Isobe M., Yagita H., Okamura K., and Ihara A. Specific acceptance of cardiac allograft after treatment with antibodies to ICAM-1 and LFA-1. Science 255 (1992) 1125-1127
27. Shimaoka M., Salas A., Yang W., Weitz-Schmidt G., and Springer T.A. Small molecule integrin antagonists that bind to the beta2 subunit I-like domain and activate signals in one direction and block them in the other. Immunity 19 (2003) 391-402
28. Holdaas H., Fellstrom B., Jardine A.G., Nyberg G., Gronhagen-Riska C., Madsen S., Neumayer H.H., Cole E., Maes B., Ambuhl P., Logan J.O., Staffler B., and Gimpelewicz C. Beneficial effect of early initiation of lipid-lowering therapy following renal transplantation. Nephrol. Dial. Transplant. 20 (2005) 974-980
29. Kobashigawa J.A., Moriguchi J.D., Laks H., Wener L., Hage A., Hamilton M.A., Cogert G., Marquez A., Vassilakis M.E., Patel J., and Yeatman L. Ten-year follow-up of a randomized trial of pravastatin in heart transplant patients. J. Heart Lung Transplant. 24 (2005) 1736-1740